Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8786045 | Clinical Oncology | 2018 | 7 Pages |
Abstract
For patients treated for a HPV+Â or HPV- OPSCC, TTI affects outcome, with the strongest effect for overall survival among HPV- patients. Reducing TTI is an important tool to improve the prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Grønhøj, D. Jensen, C. Dehlendorff, C. Nørregaard, E. Andersen, L. Specht, B. Charabi, C. von Buchwald,